102
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Chronic Obstructive Pulmonary Disease and Incidence of Hip Fracture: A Nested Case–Control Study in the EpiChron Cohort

ORCID Icon, , , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 2799-2806 | Published online: 05 Nov 2020

References

  • World Health Organization. 10 facts on ageing and health. Available from: https://www.who.int/features/factfiles/ageing/en/. Accessed 701, 2020.
  • VeroneseN, MaggiS. Epidemiology and social costs of hip fracture. Injury. 2018;49:1458–1460. doi:10.1016/j.injury.2018.04.01529699731
  • RollandY, Abellan van KanG, BenetosA, et al. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008;12:335–346.18443717
  • World Health Organization. Chronic obstructive pulmonary disease (COPD). Available from: https://www.who.int/respiratory/copd/en/. Accessed 701, 2020.
  • De BlasioF, Di GregorioA, De BlasioF, BiancoA, BellofioreB, ScalfiL. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables. Respir Med. 2018;134:1–5. doi:10.1016/j.rmed.2017.11.00629413494
  • ChenYW, RamsookAH, CoxsonHO, BonJ, ReidWD. Prevalence and risk factors for osteoporosis in individuals with COPD: a systematic review and meta-analysis. Chest. 2019;156:1092–1110. doi:10.1016/j.chest.2019.06.03631352034
  • HakamyA, BoltonCE, GibsonJE, McKeeverTM. Risk of fall in patients with COPD. Thorax. 2018;73:1079–1081. doi:10.1136/thoraxjnl-2017-21100829563161
  • HerlandT, ApalsetEM, EideGE, TellGS, LehmannS. Airflow limitation as a risk factor for low bone mineral density and hip fracture The Hordaland Health Study (HUSK) _ 10 years follow-up of a general population. Eur Clin Respir J. 2016;3:32214. doi:10.3402/ecrj.v3.3221427733234
  • Díez-ManglanoJ, López-GarcíaF, Barquero-RomeroJ, et al. Riesgo de fractura osteoporótica y de cadera en pacientes con enfermedad pulmonar obstructiva crónica. Rev Clin Esp. 2011;211:443–449. doi:10.1016/j.rce.2011.04.01021899835
  • Prados-TorresA, Poblador-PlouB, Gimeno-MiguelA, et al. Cohort profile: the epidemiology of chronic diseases and multimorbidity. The EpiChron Cohort Study. Int J Epidemiol. 2018;47:382–384. doi:10.1093/ije/dyx25929346556
  • Complete ICD-9 manual. Available from: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD-9/ucod.txt. Accessed 701, 2020.
  • YamauchiY, YasunagaH, SakamotoY, et al. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016;11:2335–2340. doi:10.2147/COPD.S11214227703343
  • De LuiseB, BrimacombeM, PedersenL, SorensenHT. Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol. 2008;23:115–122. doi:10.1007/s10654-007-9211-518038248
  • DoddAC, BulkaC, JahangirA, MirHR, ObremskeyWT, SethiMK. Predictors of 30-day mortality following hip/pelvis fractures. Orthop Traumatol Surg Res. 2016;102:707–710. doi:10.1016/j.otsr.2016.05.01627496661
  • BussL, McKeeverTM, NightingaleJ, et al. Hip fracture outcomes in patients with chronic obstructive pulmonary disease. Br J Anaesth. 2018;121:1377–1379. doi:10.1016/j.bja.2018.09.00830442271
  • ReganEA, RadcliffTA, HendersonWG, et al. Improving hip fractures outcomes for COPD patients. COPD. 2013;10:11–19. doi:10.3109/15412555.2012.72307223272668
  • SmrkeD, BiscevicM, RejecB, SmajicS. [Verlängerte Rehabilitationsdauer bei Patienten mit chronischen Lungenerkrankungen nach Schenkelhalsfrakturen]. Z Orthop Unfall. 2009;147:32–36.19263310
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020 report. Available from: https://goldcopd.org/gold-reports/. Accessed 701, 2020.
  • Graat-VerboomL, SpruitMA, Van Den BorneBE, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med. 2009;103:1143–1151. doi:10.1016/j.rmed.2009.02.01419304474
  • RommeEA, MurchisonJT, EdwardsLD, et al. CT measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes. J Bone Miner Res. 2013;28:1369–1377. doi:10.1002/jbmr.187323361992
  • HattiholiJ, GaudeGS. Prevalence and correlates of osteoporosis in chronic obstructive pulmonary disease patients in India. Lung India. 2014;31:221–227. doi:10.4103/0970-2113.13575925125807
  • KiyokawaH, MuroS, OgumaT, et al. Impact of COPD exacerbations on osteoporosis assessed by chest CT scan. COPD. 2012;9:235–242. doi:10.3109/15412555.2011.65024322360380
  • AkyeaRK, McKeeverTM, GibsonJ, ScullionJE, BoltonCE. Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study. BMJ Open. 2019;9:e024951. doi:10.1136/bmjopen-2018-024951
  • GuptaA, GreeningNJ, EvansRA, SamuelsA, TomsN, StenierM. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease. Chron Respir Dis. 2018;16:1–8.
  • LiaoKM, LiangFW, LiCY. Risks of all-cause and site-specific fractures among hospitalized patients with COPD. Medicine (Baltimore). 2016;95:e5070. doi:10.1097/MD.000000000000507027749576
  • De Miguel-diezJ, Jimenez-GarciaR, Hernande-BarreraV, et al. Is COPD a risk factor for hip fracture? COPD. 2016;13:779–789. doi:10.1080/15412555.2016.119534827379970
  • ReyesC, EstradaP, NoguésX, et al. The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study. Osteoporos Int. 2014;25:1751–1758.24676845
  • HuangSW, WangWT, ChouLC, ChenHC, LiouTH, LinHW. Chronic obstructive pulmonary disease increases the risk of hip fracture: A nationwide population-based cohort study. Sci Rep. 2016;6:23360. doi:10.1038/srep2336026987933
  • ZhengX, LiuD, ZhaoX, et al. Association of bone mineral density with lung function in a Chinese general population: the Xinxiang rural cohort study. BMC Pulm Med. 2019;19:239. doi:10.1186/s12890-019-1008-231818275
  • OshagbemiOA, BurdenAM, ShudofskyKN, et al. Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease. Bone. 2018;110:238–243. doi:10.1016/j.bone.2018.02.00729462672
  • MordenNE, SullivanSD, BartleB, LeeTA. Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int. 2011;22:1855–1862. doi:10.1007/s00198-010-1423-y20936402
  • GonzalezAV, CoulombeJ, ErnstP, SuissaS. Long-term use of inhaled corticosteroids in COPD and the risk of fracture. Chest. 2018;153:321–328. doi:10.1016/j.chest.2017.07.00228716642
  • TsaiCH, LiaoLY, LinCL, ChungWS. Inhaled corticosteroids and the risks of low-energy fractures in patients with chronic airway diseases: A propensity score matched study. Clin Respir J. 2018;12:1830–1837.29148205
  • De VriesF, PowelsS, BrackeM, et al. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf. 2007;16:612–619. doi:10.1002/pds.131816998945
  • VestergaardP, RenjmarkL, MosekildeL. Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest. 2007;132:1599–1607. doi:10.1378/chest.07-109217890464
  • Ojeda-ThiesC, Sáez-LópezP, CurrieCT, et al. Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international comparison with other established registries. Osteoporos Int. 2019;30:1243–1254. doi:10.1007/s00198-019-04939-230904929